The safety of metoclopramide use in the first trimester of pregnancy

New England Journal of Medicine

Volumn 360, Issue 24, 2009, Pages 2528-2535

  Matok, Ilan ^a   Gorodischer, Rafael ^a,b,c,d   Koren, Gideon ^d,e,f,g   Sheiner, Eyal ^a,b   Wiznitzer, Arnon ^a,b,c   Levy, Amalia ^a,d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d BeMORE Collaboration   (Israel)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f BeMORE Collaboration   (Israel)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; ENOXAPARIN; METOCLOPRAMIDE; ANTIEMETIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CIGARETTE SMOKING; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG SAFETY; ETHNICITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL DIABETES MELLITUS; NAUSEA; PARITY; PATIENT COMPLIANCE; PERINATAL DEATH; PREMATURE LABOR; PRIORITY JOURNAL; VOMITING; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; DRUG EFFECT; FETUS; LOW BIRTH WEIGHT; NEWBORN; PERINATAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; RETROSPECTIVE STUDY; RISK;

ABNORMALITIES, DRUG-INDUCED; ANTIEMETICS; COHORT STUDIES; FEMALE; FETUS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; METOCLOPRAMIDE; NAUSEA; ODDS RATIO; PERINATAL MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; RETROSPECTIVE STUDIES; VOMITING;

EID: 67149133622     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0807154     Document Type: Article

References (34)

1. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 1993;43:245-248 [Erratum, Br J Gen Pract 1993;43:325.] (Pubitemid 23203917)
2. Vellacott ID, Cooke EJ, James CE. Nausea and vomiting in early pregnancy. Int J Gynaecol Obstet 1988;27:57-62. (Pubitemid 18173813)
3. Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome: a meta-analytical review. Br J Obstet Gynaecol 1989;96:1312-1318 (Pubitemid 19275264)
4. Deuchar N. Nausea and vomiting in pregnancy: a review of the problem with particular regard to psychological and social aspects. Br J Obstet Gynaecol 1995; 102:60-68
5. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol 2002;100: 465-473 (Pubitemid 35246132)
6. American College of Obstetrics and Gynecology. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol 2004;103:803-815
7. Einarson A, Koren G, Bergman U. Nausea and vomiting in pregnancy: a comparative European study. Eur J Obstet Gynecol Reprod Biol 1998;76:1-3. (Pubitemid 28031973)
8. Pradalier A, Chabriat H, Danchot J, Baudesson G, Joire JE. Safety and efficacy of combined lysine acetylsalicylate and metoclopramide: repeated intakes in migraine attacks. Headache 1999;39:125-131 (Pubitemid 29138392)
9. Sidhu MS, Lean TH. The use of metoclopramide (Maxolon) in hyperemesis gravidarum. Proc Obstet Gynaecol Soc Singapore 1970;1:43-46
10. Rosa F. Personal communication, FDA 1993. In: Briggs GG, Freeman RK, Yaffe SJ, eds. Drugs in pregnancy and lactation: a reference guide of fetal and neonatal risk. 7th ed. Baltimore: Lippincott Williams & Wilkins, 2005:1057-1061
11. Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med 2000;343:445-446 (Pubitemid 30626134)
12. Sørensen HT, Nielsen GL, Christensen K, Tage-Jensen U, Ekbom A, Baron J. Birth outcome following maternal use of metoclopramide. Br J Clin Pharmacol 2000; 49:264-268 (Pubitemid 30150988)
13. Berkovitch M, Mazzota P, Greenberg R, et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol 2002;19:311-316
14. Central Bureau of Statistics. Statistical abstract of Israel 2008. No. 59. Population by district, subdistrict and religion. Table 2.6. (Accessed May 15, 2009, at http://www.cbs.gov.il/reader.)
15. Idem. State of Israel: Hoda'a laitonut. (Accessed May 15, 2009, at http://www.cbs.gov.il/hodaot2007n/01-07-215b.pdf.)
16. World Health Organization Collaborating Centre for Drug Statistics Methodology home page. (Accessed May 15, 2009, at http://www.whocc.no/atcddd/.)
17. Centers for Disease Control and Prevention. Metropolitan Atlanta Congenital Defects Program coding manual. (Accessed May 15, 2009, at http://www.cdc.gov/ncbddd/bd/macdp.htm.)
18. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003; 67:193-201. (Pubitemid 37238061)
19. Correa-Villaseñor A, Cragan J, Kucik J, O'Leary L, Siffel C, Williams L. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention. Birth Defects Res A Clin Mol Teratol 2003;67:617-624 (Pubitemid 37222110)
20. Ben-Joseph R, Levy A, Wiznitzer A, Holcberg G, Mazor M, Sheiner E. Pregnancy outcome of patients following deep venous thrombosis. J Matern Fetal Neonatal Med 2008:1-5.
21. Ofir D, Levy A, Wiznitzer A, Mazor M, Sheiner E. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008;141:115-118
22. Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 2002;186:Suppl:S256-S261. (Pubitemid 34533885)
23. Sheiner E, Shoham-Vardi I, Sheiner EK, Mazor M, Katz M, Carmi R. Maternal factors associated with severity of birth defects. Int J Gynaecol Obstet 1999;64:227-232 (Pubitemid 29170037)
24. Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R. Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol 1998;76:141-146 (Pubitemid 28031901)
25. Tricco AC, Pham B, Rawson NS. Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol 2008; 61:192-197
26. Misset B, Nakache D, Vesin A, et al. Reliability of diagnostic coding in intensive care patients. Crit Care 2008;12:R95.
27. Louik C, Hernandez-Diaz S, Werler MM, Mitchell AA. Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr Perinat Epidemiol 2006;20:270-278 (Pubitemid 43882160)
28. Meyerovitch J, Sherf M, Antebi F, et al. The incidence of anemia in an Israeli population: a population analysis for anemia in 34,512 Israeli infants aged 9 to 18 months. Pediatrics 2006;118:e1055-e1160. (Pubitemid 46393754)
29. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837-849 (Pubitemid 19094261)
30. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-1112
31. Johnson RE, Vollmer WM. Comparing sources of drug data about the elderly. J Am Geriatr Soc 1991;39:1079-1084
32. De Jong van den Berg LT, Feenstra N, Sorensen HT, Cornel MC. Improvement of drug exposure data in a registration of congenital anomalies - pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. Teratology 1999;60:33-36 (Pubitemid 29338853)
33. Boneva RS, Moore CA, Botto L, Wong LY, Erickson JD. Nausea during pregnancy and congenital heart defects: a population-based case-control study. Am J Epidemiol 1999;149:717-725 (Pubitemid 29180780)
34. Källén B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol 1987;26:291-302. (Pubitemid 17163069)